Novo Nordisk's pricing techniques from the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, who may have accused the company of selling price gouging, declaring the stark distinction involving U.S. selling prices and those in Europe and copyright.This led Novo Nordisk to conduct more investigation into bigger dosages of semaglut